Related Experiment Videos
[Dermo-epidermal interactions and skin pharmacology].
1INSERM 312, Laboratoire Pharmacologie Cutanée, Hôpital Henri-Mondor, Créteil, France.
Pathologie-Biologie
|February 1, 1992
Summary
This study developed a living skin equivalent model for in vitro skin research. The model revealed that fibroblasts influence epidermal growth and keratinocyte proliferation, impacting drug responses.
Area of Science:
- Dermatology
- Tissue Engineering
- Cell Biology
Context:
- Developing in vitro models is crucial for studying skin biology and pharmacology.
- Living skin equivalents mimic in vivo skin structure and cellular differentiation.
- This model allows for the investigation of dermal-epidermal interactions.
Purpose:
- To create a simplified, two-step living skin equivalent model.
- To analyze the influence of dermal components on epidermal cells.
- To study the effects of fibroblasts and pharmacological agents on skin cells.
Summary:
- A dermal equivalent is formed first, followed by the addition of an epidermal equivalent.
- Normal fibroblasts promote epidermal growth, while psoriatic fibroblasts increase keratinocyte proliferation.
- Fibroblasts modulate the effects of pharmacological agents, such as retinoids, on keratinocytes.
Impact:
- Provides a valuable in vitro tool for skin research and drug development.
- Enhances understanding of fibroblast-keratinocyte interactions in normal and diseased skin.
- Facilitates the study of how external agents affect skin at a cellular level.